A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Clinical trial NCT05953480 · COMPLETED

Trial details

NCT number: NCT05953480
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2023-07-14
Primary completion: 2026-06-15
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.